Drug Interaction in Infectious Diseases

Drug interactions in infectious diseases are a major source of medical harm that can be avoided. Patients are exposed to a high risk of drug interactions. Drug interactions provide a significant issue for patients and their care providers, according to the approved drug product labels for anti-infective medications, direct-acting antivirals for HCV, and HIV medications. Interactions could also be caused by non-CYP enzymes, CYP enzymes, and variations in stomachic pH, as well as the ever-growing list of drug transporters. Interactions caused by dietary components, flavouring drugs, and biological products are among the other problems.

 

  • Fluoxetine and Phenelzine
  • Digoxin and Quinidine
  • Warfarin and Diflunisal
  • Theophylline and Ciprofloxacin

Related Conference of Drug Interaction in Infectious Diseases

August 28-29, 2025

8th Pathology and Infectious Disease Conference

London, UK
September 22-23, 2025

11th International Conference on Infectious and Rare Diseases

Vancouver, Canada
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic
December 15-16, 2025

7th Global Experts Meeting on Infectious Diseases

Barcelona, Spain
December 17-18, 2025

17th Global Conference on Nephrology and Infectious Diseases

Amsterdam, Netherlands

Drug Interaction in Infectious Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in